1-Oxaspiro(4.5)decan-2-one, 8-(1-methylethyl)-, trans-
Common Name: |
1-Oxaspiro(4.5)decan-2-one, 8-(1-methylethyl)-, trans- |
IUPAC Name: |
8-propan-2-yl-1-oxaspiro[4.5]decan-2-one |
Molecular Formula: |
C12H20O2 |
SMILES: |
CC(C)C1CCC2(CC1)CCC(=O)O2 |
Inchi: |
1S/C12H20O2/c1-9(2)10-3-6-12(7-4-10)8-5-11(13)14-12/h9-10H,3-8H2,1-2H3 |
Inchi Key: |
VPSQYLNVIBQLTO-UHFFFAOYSA-N |
Cas No: |
4625-90-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
196.29 |
Mass (g/mol) |
196.146 |
Molar Refractivity |
56.89 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
1 |
Rings |
2 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
279.00 to 281.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.004 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.92 |
LogP |
2.908 |
iLOGP |
2.59 |
XLOGP3 |
2.86 |
WLOGP |
2.91 |
MLOGP |
2.76 |
ESOL Log S |
-2.79 |
ESOL Solubility (mg/ml) |
0.316 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.07 |
Ali Solubility (mg/ml) |
0.17 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.59 |
Silicos-IT Solubility (mg/ml) |
0.5 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.47 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.103 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.764 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |